How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Patients' Access to Treatments Act of 2015
Client: LUPUS FOUNDATION OF AMERICA · Firm: LUPUS FOUNDATION OF AMERICA
Fiscal Year 2017 LHHS and DoD appropriations for National lupus patient registry at CDC, National Health Education in Lupus Program at OMH, NIH funding, lupus in the DoD Peer-Reviewed Medical Research Program HR 1600 - Patients' Access to Treatments Act, Congressional Lupus Caucus, Health disparities in lupus, increasing cost of generic medications,
Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015
Client: LUPUS FOUNDATION OF AMERICA · Firm: LUPUS FOUNDATION OF AMERICA
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
LUPUS FOUNDATION OF AMERICA via LUPUS FOUNDATION OF AMERICA
2016 · second_quarter · Q2
Fiscal Year 2017 LHHS and DoD appropriations for National lupus patient registry at CDC, National Health Education in Lupus Program at OMH, NIH funding, Congressional Lupus Caucus, Health disparities in lupus, Medicare Part D program,lupus awareness, compounded medications-quinacrine, Medicare Part B Demonstration
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
National lupus patient registry at CDC, Patients' Access to Treatments Act, Congressional Lupus Caucus, Health disparities in lupus, increasing cost of generic medications, HR 1576-Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015
Patients' Access to Treatments Act of 2015
Client: LUPUS FOUNDATION OF AMERICA · Firm: LUPUS FOUNDATION OF AMERICA
National lupus patient registry at CDC, Promoted the new National Public Health Agenda for Lupus, HR 1600 - Patients' Access to Treatments Act, Congressional Lupus Caucus, Health disparities in lupus, increasing cost of generic medications, NIH funding, lupus in the DoD Peer-Reviewed Medical Research Program
Patients' Access to Treatments Act of 2013
Client: LUPUS FOUNDATION OF AMERICA · Firm: LUPUS FOUNDATION OF AMERICA
FY2105 appropriations (Labor/HHS and DoD): specifically, National Lupus Patient Registry; The Lupus Initiative; National Lupus Patient Registry; Medicare Part D and the Proposed Rule regarding changes to the 6 protected classes; Patients' Access to Treatments Act (HR 460)
Patients' Access to Treatments Act of 2013
Client: LUPUS FOUNDATION OF AMERICA · Firm: LUPUS FOUNDATION OF AMERICA
Medicare Part D Appeals; Patients' Access to Treatments Act (HR460) and specialty tiers; NIH Research Funding; National Lupus Patient Registry
Patients' Access to Treatments Act of 2013
Client: LUPUS FOUNDATION OF AMERICA · Firm: LUPUS FOUNDATION OF AMERICA
Patients' Access to Treatments Act (H.R. 460); Fiscal Year 2014 Labor/HHS Appropriations (NIH and OMH), Fiscal Year 2014 Department of Defense Appropriations (Peer Reviewed Medical Research Program); National Lupus Patient Registry-CDC
Patients' Access to Treatments Act of 2013
Client: LUPUS FOUNDATION OF AMERICA · Firm: LUPUS FOUNDATION OF AMERICA
Labor/HHS Appropriations, H.R. 460-Patients' Access to Treatments Act, NIH, CDC, OMH, Compassionate Allowances Program at SSA
Patients' Access to Treatments Act of 2013
Client: LUPUS FOUNDATION OF AMERICA · Firm: LUPUS FOUNDATION OF AMERICA
lighting and lupus; National Lupus Patient Registry and health disparities in lupus; Patients' Access to Treatments Act (HR 460); 10th Anniversary of Medicare Part D; Social Security Disability and Chained CPI and Unempolyment Income
Patients' Access to Treatments Act of 2012
Client: LUPUS FOUNDATION OF AMERICA · Firm: LUPUS FOUNDATION OF AMERICA
FY2013 Appropriations (LHHS and DoD); HR4209-Access to Affordable Treatments; Specialty Tiers and out of pocket costs for medications; Congressional Lupus Caucus recruitment; National Lupus Patient Registry at CDC; Lupus research at NIAMS
2016 · first_quarter · Q1
Fiscal Year 2017 LHHS and DoD appropriations for National lupus patient registry at CDC, National Health Education in Lupus Program at OMH, NIH funding, lupus in the DoD Peer-Reviewed Medical Research Program HR 1600 - Patients' Access to Treatments Act, Congressional Lupus Caucus, Health disparities in lupus, increasing cost of generic medications,
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
LUPUS FOUNDATION OF AMERICA via LUPUS FOUNDATION OF AMERICA
2015 · fourth_quarter · Q4
National lupus patient registry at CDC, Promoted the new National Public Health Agenda for Lupus, HR 1600 - Patients' Access to Treatments Act, Congressional Lupus Caucus, Health disparities in lupus, increasing cost of generic medications, NIH funding, lupus in the DoD Peer-Reviewed Medical Research Program
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LUPUS FOUNDATION OF AMERICA via LUPUS FOUNDATION OF AMERICA
2015 · third_quarter · Q3
National lupus patient registry at CDC, Patients' Access to Treatments Act, Congressional Lupus Caucus, Health disparities in lupus, increasing cost of generic medications, HR 1576-Generic Complex Drugs Safety and Effectiveness for Patients Act of 2015
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
LUPUS FOUNDATION OF AMERICA via LUPUS FOUNDATION OF AMERICA
2015 · second_quarter · Q2
House Labor/HHS FY2016 appropriations, Senate Labor/HHS and DoD FY2016 appropriations, national lupus patient registry at CDC, Patients' Access to Treatments Act, 21st Century Cures Act, Congressional Lupus Caucus, Health disparities in lupus.
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
LUPUS FOUNDATION OF AMERICA via LUPUS FOUNDATION OF AMERICA
2015 · first_quarter · Q1
Lupus Initiative at HHS, House Labor/HHS FY2016 appropriations, Senate Labor/HHS and DoD FY2016 appropriations, national lupus patient registry at CDC, the future directions of lupus research at NIH, lupus clinical trials at FDA, Patients' Access to Treatments Act, biosimilar safety, 21st Century Cures Act.
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
LUPUS FOUNDATION OF AMERICA via LUPUS FOUNDATION OF AMERICA
2014 · fourth_quarter · Q4
Diagnostic Testing in Lupus, Congressional Lupus Caucus, 21st Century Cures, National Lupus Patient Registry
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
LUPUS FOUNDATION OF AMERICA via LUPUS FOUNDATION OF AMERICA
2014 · third_quarter · Q3
Medicare Part D Appeals; Patients' Access to Treatments Act (HR460) and specialty tiers; NIH Research Funding; National Lupus Patient Registry
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
LUPUS FOUNDATION OF AMERICA via LUPUS FOUNDATION OF AMERICA
2014 · second_quarter · Q2
The Lupus Initiative (OMH); National Lupus Patient Registry (CDC); funding for lupus research; co-insurance rates for prescription medications;
Filing targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
LUPUS FOUNDATION OF AMERICA via LUPUS FOUNDATION OF AMERICA
2014 · first_quarter · Q1
FY2105 appropriations (Labor/HHS and DoD): specifically, National Lupus Patient Registry; The Lupus Initiative; National Lupus Patient Registry; Medicare Part D and the Proposed Rule regarding changes to the 6 protected classes; Patients' Access to Treatments Act (HR 460)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
LUPUS FOUNDATION OF AMERICA via LUPUS FOUNDATION OF AMERICA
2013 · fourth_quarter · Q4
lighting and lupus; National Lupus Patient Registry and health disparities in lupus; Patients' Access to Treatments Act (HR 460); 10th Anniversary of Medicare Part D; Social Security Disability and Chained CPI and Unempolyment Income
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LUPUS FOUNDATION OF AMERICA via LUPUS FOUNDATION OF AMERICA
2013 · third_quarter · Q3
Patients' Access to Affordable Treatments Act; Part D Beneficiary Appeals Fairness Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LUPUS FOUNDATION OF AMERICA via LUPUS FOUNDATION OF AMERICA
2013 · second_quarter · Q2
Labor/HHS Appropriations, H.R. 460-Patients' Access to Treatments Act, NIH, CDC, OMH, Compassionate Allowances Program at SSA
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Social Security Administration (SSA)
LUPUS FOUNDATION OF AMERICA via LUPUS FOUNDATION OF AMERICA
2013 · first_quarter · Q1
Patients' Access to Treatments Act (H.R. 460); Fiscal Year 2014 Labor/HHS Appropriations (NIH and OMH), Fiscal Year 2014 Department of Defense Appropriations (Peer Reviewed Medical Research Program); National Lupus Patient Registry-CDC
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE
LUPUS FOUNDATION OF AMERICA via LUPUS FOUNDATION OF AMERICA
2012 · fourth_quarter · Q4
Medicare Part D, Essential Health Benefits, National Lupus Patient Registry at CDC, lupus nephritis guidelines at FDA
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
LUPUS FOUNDATION OF AMERICA via LUPUS FOUNDATION OF AMERICA
2012 · third_quarter · Q3
Congressional Lupus Caucus recruitment; Sequestration; Lupus research and awareness
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LUPUS FOUNDATION OF AMERICA via LUPUS FOUNDATION OF AMERICA
2012 · second_quarter · Q2
FY2013 Appropriations (LHHS and DoD); HR4209-Access to Affordable Treatments; Specialty Tiers and out of pocket costs for medications; Congressional Lupus Caucus recruitment; National Lupus Patient Registry at CDC; Lupus research at NIAMS
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
LUPUS FOUNDATION OF AMERICA via LUPUS FOUNDATION OF AMERICA
2012 · first_quarter · Q1
HHS--Office on Women's Health and Surgeon General discussing lupus education and awareness; Centers for Disease Control and Prevention--National Lupus Patient Registry; House Labor/HHS (NIH and CDC) and DoD Appropriations (Peer Reviewed Medical Research Program); Senate Labor/HHS (NIH and CDC) and DoD Appropriations (Peer Reviwed Medical Research Program)
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
LUPUS FOUNDATION OF AMERICA via LUPUS FOUNDATION OF AMERICA
2011 · fourth_quarter · Q4
National Lupus Patient Registry (CDC); Congressional Lupus Caucus (House); FY 12 Appropriations (Senate); Medicare Part D (House)
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, SENATE